FR2659449A1 - - Google Patents

Download PDF

Info

Publication number
FR2659449A1
FR2659449A1 FR9102741A FR9102741A FR2659449A1 FR 2659449 A1 FR2659449 A1 FR 2659449A1 FR 9102741 A FR9102741 A FR 9102741A FR 9102741 A FR9102741 A FR 9102741A FR 2659449 A1 FR2659449 A1 FR 2659449A1
Authority
FR
France
Prior art keywords
cancer
serodiagnosis
serodiagnostic
histone
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR9102741A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga and Co Ltd
Original Assignee
Morinaga and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5723690A external-priority patent/JPH03257367A/ja
Priority claimed from JP13914690A external-priority patent/JPH0432766A/ja
Application filed by Morinaga and Co Ltd filed Critical Morinaga and Co Ltd
Publication of FR2659449A1 publication Critical patent/FR2659449A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795Porphyrin- or corrin-ring-containing peptides
    • G01N2333/80Cytochromes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9102741A 1990-03-08 1991-03-07 Withdrawn FR2659449A1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5723690A JPH03257367A (ja) 1990-03-08 1990-03-08 血清診断法
JP13914690A JPH0432766A (ja) 1990-05-29 1990-05-29 血清診断法

Publications (1)

Publication Number Publication Date
FR2659449A1 true FR2659449A1 (ko) 1991-09-13

Family

ID=26398252

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9102741A Withdrawn FR2659449A1 (ko) 1990-03-08 1991-03-07

Country Status (4)

Country Link
KR (1) KR910017189A (ko)
DE (1) DE4107334A1 (ko)
FR (1) FR2659449A1 (ko)
GB (1) GB2241782B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807999A (en) * 1993-02-01 1998-09-15 Mt. Sinai School Of Medicine Of The City University Of New York Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor
WO2001035093A1 (fr) * 1999-11-08 2001-05-17 Eisai Co. Ltd. Methode de detection de la mort cellulaire, et reactif de detection
US7138239B2 (en) 2001-05-09 2006-11-21 Eisai Co., Ltd. Method and reagent for testing for multiple organ failure in SIRS by cytochrome C measurement
EP1501869A4 (en) * 2001-08-03 2006-01-11 Univ Virginia PHOSPHORYLATED HISTON H2B AS APOPTOSEMARKER

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906819A (en) * 1958-04-28 1962-09-26 Masaka Matsubara Parenteral solution for diagnostic test of cancer and a process of preparing same
DE3737274A1 (de) * 1987-11-03 1989-06-01 Rusch Volker Verwendung von reinem h2a- und/oder h2b-histon als wirksubstanz zur herstellung von arzneimitteln
WO1989005455A1 (en) * 1987-12-02 1989-06-15 The Regents Of The University Of California Aids-related anti-t-cell antibody test
GB2218807A (en) * 1988-05-13 1989-11-22 Morinaga & Co Serodiagnosis method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906819A (en) * 1958-04-28 1962-09-26 Masaka Matsubara Parenteral solution for diagnostic test of cancer and a process of preparing same
DE3737274A1 (de) * 1987-11-03 1989-06-01 Rusch Volker Verwendung von reinem h2a- und/oder h2b-histon als wirksubstanz zur herstellung von arzneimitteln
WO1989005455A1 (en) * 1987-12-02 1989-06-15 The Regents Of The University Of California Aids-related anti-t-cell antibody test
GB2218807A (en) * 1988-05-13 1989-11-22 Morinaga & Co Serodiagnosis method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE JOURNAL OF RHEUMATOLOGY vol. 13, no. 4, 1986, pages 722 - 725 COSTA ET AL. 'Antihistone antibodies detected by ELISA ......' *

Also Published As

Publication number Publication date
GB9104915D0 (en) 1991-04-24
GB2241782A (en) 1991-09-11
KR910017189A (ko) 1991-11-05
DE4107334A1 (de) 1991-09-12
GB2241782B (en) 1993-12-08

Similar Documents

Publication Publication Date Title
BE1000611A5 (fr) Anticorps monoclonaux et antigene du carcinome pulmonaire humain a cellules non petites et de certains autres carcinomes humains.
EA002520B1 (ru) Выделенное антитело и его фрагмент, способы и набор для оценки уровня перекисного окисления липидов в биологическом образце и способ диагностики заболеваний, обусловленных перекисным окислением липидов
JPS60500716A (ja) ウイルス腫瘍遺伝子からの合成ポリペプチド
FR2521303A1 (fr) Procede de determination immunologique d'anticorps de type immunoglobuline de classe specifique
Ten Have-Opbroek Immunological study of lung development in the mouse embryo: II. First appearance of the great alveolar cell, as shown by immunofluorescence microscopy
FR2464995A1 (fr) Procede de preparation d'une sous-population virale ayant une sensibilite accrue envers des cellules-hotes du virus et applications de cette sous-population
JP2598893B2 (ja) 特異性ceaファミリー抗原に対し特異性の抗体を使用するイム/アッセイ
FR2659449A1 (ko)
FR2484650A1 (fr) Procede de detection des cellules cancereuses humaines avec des anticorps contre les antigenes nucleolaires des cancers humains
FR2601781A1 (fr) Reactif de dosage de mycotoxine et methode l'utilisant pour doser une mycotoxine
FR2631450A1 (fr) Methode de serodiagnostic
FR2531223A1 (fr) Procede et reactif de dosage immunologique
EP0206849B1 (fr) Moyens pour le diagnostic in vitro de cellules malignes originaires du tube digestif
US5137807A (en) Method for determining beta-subunit of human prolyl 4-hydroxylase by immunoassay to detect hepatic disease
EP0345315B1 (fr) Peptides derives de la proteine ps2
EP1301791B1 (fr) Dispositif et procede de detection moleculaire
JPS62179399A (ja) 抗原gp650に特異的なモノクロ−ナル抗体によるヒトのガンの検出
EP1478623A1 (fr) Nouveaux agents de couplages, leurs intermediaires actives, leurs conjugues, ainsi que l'utilisation de ces conjugues dans des methodes de diagnostic
EP0192565A1 (fr) Procédé de dosage immunologique des amines, anticorps monoclonaux et ensemble de réactifs pour la mise en oeuvre du procédé
JP2946216B2 (ja) 新規ハイブリドーマ,モノクローナル抗体および用途
EP0785432B1 (fr) Procédé pour l'identification ou le dosage immunologique d'antigènes polypeptidiques
EP0193935A2 (en) Method for determining human prolyl 4-hydroxylase by immunoassay
US4876192A (en) Detection of antibodies against a chorionic gonadotropin-like substance
JP2000224986A (ja) 可溶性グアニル酸シクラーゼに特異的なモノクローナル抗体
JP3036545B2 (ja) モノクローナル抗体とこれを産生するハイブリドーマ細胞株、およびこれを用いる免疫学的測定法

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 37/91

ST Notification of lapse